Clinical Trials
205 trialsA Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
LEARN
University of Sydney
KCC-S
University of Utah
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
iCaRe2
University of Nebraska
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
BASECAMP-1
A2 Biotherapeutics Inc.
ELEPHAS-02
Elephas
FRISC
Centre Hospitalier Universitaire, Amiens
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
National Institutes of Health Clinical Center (CC)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
National Institutes of Health Clinical Center (CC)
BIOSUNTOX
University Hospital, Rouen
RCCETT
Peking University Third Hospital
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
SMART
University of Alberta
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
NEPHRAMBU
GCS Ramsay Santé pour l'Enseignement et la Recherche
PP-RECURK
Gødstrup Hospital
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
KIDCaD
Charles University, Czech Republic
SPECT/CT for the Characterization of Renal Masses
Jonsson Comprehensive Cancer Center
DISSRM
Abramson Cancer Center at Penn Medicine
OCCURORTW
Jagiellonian University
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Mayo Clinic
WASHOUT
British Urology Researchers in Surgical Training
COSTAR
Peking University First Hospital
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
Istituto Clinico Humanitas
CAMPERR
Adela, Inc
Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ELEPHAS-05
Elephas
COSMO
Harvard Medical School (HMS and HSDM)
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Palo Alto Veterans Institute for Research
AI for Renal Tumors Using Non-Contrast CT
Fudan University
IMPLICATION
Centre Hospitalier Universitaire de Besancon
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Jinling Hospital, China
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
GenCInibs-Suni
Centre Hospitalier Universitaire de Nīmes
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
LIBERATE
University Health Network, Toronto
BLUSH
Vastra Gotaland Region
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
The University of Texas Health Science Center at San Antonio